Table 3 Clinicopathological characteristics of patients stratified by post-CRT LCR
Characteristic | LCR low (n = 24) | LCR high (n = 24) | P value |
|---|---|---|---|
Age (years) | 67 ± 13 | 64 ± 9 | 0.36 |
Gender (male/female) | 17/7 | 15/9 | 0.54 |
WBC (/μL) | 5391 ± 1652 | 4441 ± 1127 | 0.06 |
TLC (/μL) | 730 ± 460 | 971 ± 347 | < 0.05 |
Alb (mg/dL) | 3.4 ± 0.5 | 3.9 ± 0.4 | 0.91 |
CRP (mg/dL) | 1.10 ± 1.60 | 0.26 ± 0.71 | < 0.05 |
Pre-CRT LCR | 9006 ± 9368 | 23322 ± 13945 | < 0.05 |
Tumor characteristic | |||
 Differentiation (tub1/tub2/other) | 9/14/1 | 10/13/1 | 0.41 |
 CEA (</≥ 5 ng/mL) | 18/6 | 16/8 | 0.53 |
 CA19-9 (</≥ 37 IU/mL) | 20/4 | 20/4 | 1.00 |
 Pre-CRT stage (I/II/II) | 1/3/15 | 2/8/13 | 0.20 |
Treatment | |||
 Chemotherapy (S-1/UFT/5FU) | 12/9/3 | 17/2/5 | 0.05 |
 Surgery (LAR/ISR/APR/local) | 9/3/11/1 | 9/7/7/1 | 0.47 |
Pathological response (grade 2/≥ 2) | 16/8 | 16/8 | 1.00 |